Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Trimmed by Clare Market Investments LLC

Clare Market Investments LLC cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 28.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 14,238 shares of the biotechnology company's stock after selling 5,797 shares during the quarter. Axon Enterprise accounts for about 2.0% of Clare Market Investments LLC's investment portfolio, making the stock its 13th largest holding. Clare Market Investments LLC's holdings in Axon Enterprise were worth $7,488,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. TrueWealth Advisors LLC boosted its stake in Axon Enterprise by 3.5% in the first quarter. TrueWealth Advisors LLC now owns 1,090 shares of the biotechnology company's stock valued at $573,000 after acquiring an additional 37 shares during the period. Hennion & Walsh Asset Management Inc. grew its stake in Axon Enterprise by 20.6% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 8,645 shares of the biotechnology company's stock worth $4,547,000 after buying an additional 1,476 shares during the last quarter. Merit Financial Group LLC increased its position in Axon Enterprise by 160.5% in the first quarter. Merit Financial Group LLC now owns 14,535 shares of the biotechnology company's stock worth $7,645,000 after buying an additional 8,956 shares during the period. NBC Securities Inc. lifted its stake in Axon Enterprise by 119,666.7% in the first quarter. NBC Securities Inc. now owns 3,593 shares of the biotechnology company's stock valued at $1,889,000 after buying an additional 3,590 shares during the last quarter. Finally, Czech National Bank boosted its holdings in shares of Axon Enterprise by 5.9% during the first quarter. Czech National Bank now owns 16,638 shares of the biotechnology company's stock valued at $8,751,000 after acquiring an additional 931 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Buying and Selling

In other news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 9,000 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $683.31, for a total value of $6,149,790.00. Following the sale, the president now directly owns 308,714 shares in the company, valued at $210,947,363.34. This trade represents a 2.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,969 shares of company stock worth $29,909,594. Corporate insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Bank of America boosted their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group boosted their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average price target of $699.55.

Axon Enterprise Price Performance

Shares of AXON traded up $3.49 during midday trading on Friday, reaching $791.85. The stock had a trading volume of 443,537 shares, compared to its average volume of 731,575. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $61.65 billion, a P/E ratio of 204.61, a P/E/G ratio of 5.17 and a beta of 1.24. The firm's 50 day moving average price is $638.88 and its 200-day moving average price is $615.19. Axon Enterprise, Inc. has a 52 week low of $278.24 and a 52 week high of $798.16.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise's revenue was up 31.3% on a year-over-year basis. During the same period in the prior year, the company earned $1.15 EPS. On average, analysts forecast that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.